John W. Childs

John W. Childs

Board Member · Biohaven Ltd.

Rank #740 SEC EDGAR (United States) ↗ Files from United States

Details

Member of the boardPharmaceuticals & BiotechnologyUnited StatesColumbia Business SchoolYale UniversityBHVNSEC CIK 0001027035

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$183.9M
1-day change
▼ 0.79%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 31 weekly points

What the 2 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2026-02-06$101.9M – $195.8M2026-09-04

Insider activity Apr 5, 2024 – Feb 5, 2026

John W. Childs is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 19 transactions between Apr 5, 2024 and Feb 5, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$44.91M
15 purchases on file priced rows only
Open-market sales (code S)
None
0 sales on file
All reported transactions
19
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought Veradermics, Inc (MANE) shares worth $34,817,458 between Feb 4, 2026 and Feb 6, 2026

Cluster buying

4 different insiders made 23 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

4 insiders bought Veradermics, Inc (MANE) shares worth $34,817,458 between Feb 4, 2026 and Feb 6, 2026
Date Insider Transaction Shares Price Value Filing
Feb 4, 2026 Aaron Cowen P Open-market purchase 3,178 held after: 393,732 $38.90 $123,624 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 10,004 held after: 3,525,462 $34.25 $342,637 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 10,676 held after: 3,536,138 $34.74 $370,884 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 14,659 held after: 3,550,797 $36.27 $531,682 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 53,344 held after: 3,604,141 $37.11 $1,979,596 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 25,908 held after: 3,630,049 $38.09 $986,836 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 18,489 held after: 3,648,538 $38.90 $719,222 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 1,720 held after: 372,579 $34.25 $58,910 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 1,835 held after: 374,414 $34.74 $63,748 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 2,519 held after: 376,933 $36.27 $91,364 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 9,168 held after: 386,101 $37.11 $340,224 SEC filing ↗
Feb 4, 2026 Aaron Cowen P Open-market purchase 4,453 held after: 390,554 $38.09 $169,615 SEC filing ↗
Feb 5, 2026 John W. Childs P Open-market purchase 294,117 held after: 294,117 $17.00 $4,999,989 SEC filing ↗
Feb 5, 2026 Patrick G. Enright P Open-market purchase 882,353 held after: 2,053,474 $17.00 $15,000,001 SEC filing ↗
Feb 5, 2026 Patrick G. Enright P Open-market purchase 192,647 held after: 2,600,399 $17.00 $3,274,999 SEC filing ↗
Feb 5, 2026 Vlad Coric P Open-market purchase 58,823 held after: 319,398 $17.00 $999,991 SEC filing ↗
Feb 5, 2026 Aaron Cowen P Open-market purchase 3,832 held after: 397,564 $36.07 $138,220 SEC filing ↗
Feb 5, 2026 Aaron Cowen P Open-market purchase 19,199 held after: 416,763 $36.93 $709,019 SEC filing ↗
Feb 5, 2026 Aaron Cowen P Open-market purchase 38,771 held after: 455,534 $37.63 $1,458,953 SEC filing ↗
Feb 5, 2026 Aaron Cowen P Open-market purchase 17,835 held after: 473,369 $38.67 $689,679 SEC filing ↗
Feb 5, 2026 Aaron Cowen P Open-market purchase 16,563 held after: 489,932 $39.80 $659,207 SEC filing ↗
Feb 6, 2026 Aaron Cowen P Open-market purchase 11,183 held after: 501,115 $35.97 $402,253 SEC filing ↗
Feb 6, 2026 Aaron Cowen P Open-market purchase 19,338 held after: 520,453 $36.55 $706,804 SEC filing ↗

Total of the rows above: $34,817,458, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

4 insiders bought Biohaven Ltd. (BHVN) shares worth $33,144,833 between Nov 13, 2025 and Nov 17, 2025

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

4 insiders bought Biohaven Ltd. (BHVN) shares worth $33,144,833 between Nov 13, 2025 and Nov 17, 2025
Date Insider Transaction Shares Price Value Filing
Nov 13, 2025 John W. Childs P Open-market purchase 3,333,333 held after: 5,653,904 $7.50 $24,999,998 SEC filing ↗
Nov 13, 2025 Gregory Bailey P Open-market purchase 400,000 held after: 2,020,071 $7.50 $3,000,000 SEC filing ↗
Nov 13, 2025 Vlad Coric P Open-market purchase 333,333 held after: 740,546 $7.50 $2,499,998 SEC filing ↗
Nov 13, 2025 Vlad Coric P Open-market purchase 333,333 held after: 1,195,275 $7.50 $2,499,998 SEC filing ↗
Nov 17, 2025 George C Clark P Open-market purchase 17,000 held after: 20,000 $8.52 $144,840 SEC filing ↗

Total of the rows above: $33,144,833, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

John W. Childs bought 3,333,333 Biohaven Ltd. (BHVN) shares for $24,999,998 on Nov 13, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

John W. Childs bought 3,333,333 Biohaven Ltd. (BHVN) shares for $24,999,998 on Nov 13, 2025
Date Insider Transaction Shares Price Value Filing
Nov 13, 2025 John W. Childs P Open-market purchase 3,333,333 held after: 5,653,904 $7.50 $24,999,998 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

3 insiders bought Biohaven Ltd. (BHVN) shares worth $2,220,890 between Sep 24, 2024 and Oct 2, 2024

Cluster buying

3 different insiders made 3 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Biohaven Ltd. (BHVN) shares worth $2,220,890 between Sep 24, 2024 and Oct 2, 2024
Date Insider Transaction Shares Price Value Filing
Sep 24, 2024 Gregory Bailey P Open-market purchase 5,000 held after: 1,620,071 $44.19 $220,950 SEC filing ↗
Oct 2, 2024 John W. Childs P Open-market purchase 21,052 held after: 21,052 $47.50 $999,970 SEC filing ↗
Oct 2, 2024 Vlad Coric P Open-market purchase 21,052 held after: 861,942 $47.50 $999,970 SEC filing ↗

Total of the rows above: $2,220,890, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

3 insiders bought Biohaven Ltd. (BHVN) shares worth $17,514,335 between Apr 22, 2024 and May 13, 2024

Cluster buying

3 different insiders made 8 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Biohaven Ltd. (BHVN) shares worth $17,514,335 between Apr 22, 2024 and May 13, 2024
Date Insider Transaction Shares Price Value Filing
Apr 22, 2024 John W. Childs P Open-market purchase 97,560 held after: 4,096,512 $41.00 $3,999,960 SEC filing ↗
Apr 22, 2024 John W. Childs P Open-market purchase 24,391 held after: 24,391 $41.00 $1,000,031 SEC filing ↗
Apr 22, 2024 John W. Childs P Open-market purchase 73,170 held after: 73,170 $41.00 $2,999,970 SEC filing ↗
Apr 22, 2024 Gregory Bailey P Open-market purchase 48,780 held after: 1,574,568 $41.00 $1,999,980 SEC filing ↗
Apr 22, 2024 Vlad Coric P Open-market purchase 121,951 held after: 1,788,417 $41.00 $4,999,991 SEC filing ↗
Apr 24, 2024 Gregory Bailey P Open-market purchase 25,503 held after: 1,600,071 $39.18 $999,208 SEC filing ↗
May 13, 2024 John W. Childs P Open-market purchase 28,500 held after: 2,283,341 $35.17 $1,002,345 SEC filing ↗
May 13, 2024 Gregory Bailey P Open-market purchase 15,000 held after: 1,615,071 $34.19 $512,850 SEC filing ↗

Total of the rows above: $17,514,335, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 22 most recent rows are grouped into 12 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Veradermics, Inc MANE S Open-market sale × 3 100,000 shares $10.71M
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    5,000 $108.24 $541.2K SEC filing ↗
    80,000 $107.23 $8.58M SEC filing ↗
    15,000 $106.14 $1.59M SEC filing ↗
  2. Veradermics, Inc MANE C Conversion of derivative × 3not a buy/sell decisionreported at zero 1,907,889 shares $0
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    480,269 $0.00reported at zero $0 SEC filing ↗
    520,758 $0.00reported at zero $0 SEC filing ↗
    906,862 $0.00reported at zero $0 SEC filing ↗
  3. Veradermics, Inc MANE P Open-market purchase 294,117 shares $5.00M at $17.00 SEC filing ↗
  4. Biohaven Ltd. BHVN P Open-market purchase 3,333,333 shares $25.00M at $7.50 SEC filing ↗
  5. Biohaven Ltd. BHVN P Open-market purchase × 5 61,100 shares $1.86M
    The 5 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    28,400 $30.43 $864.2K SEC filing ↗
    25,000 $30.39 $759.8K SEC filing ↗
    3,400 $30.73 $104.5K SEC filing ↗
    3,400 $30.73 $104.5K SEC filing ↗
    900 $30.73 $27.7K SEC filing ↗
  6. Biohaven Ltd. BHVN P Open-market purchase 29,000 shares $1.04M at $35.94 SEC filing ↗
  7. Biohaven Ltd. BHVN P Open-market purchase 21,052 shares $1,000.0K at $47.50 SEC filing ↗
  8. Biohaven Ltd. BHVN P Open-market purchase 28,400 shares $1.01M at $35.67 SEC filing ↗
  9. Biohaven Ltd. BHVN P Open-market purchase 28,000 shares $996.2K at $35.58 SEC filing ↗
  10. Biohaven Ltd. BHVN P Open-market purchase 28,500 shares $1.00M at $35.17 SEC filing ↗
  11. Biohaven Ltd. BHVN P Open-market purchase × 3 195,121 shares $8.00M
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    73,170 $41.00 $3.00M SEC filing ↗
    24,391 $41.00 $1.00M SEC filing ↗
    97,560 $41.00 $4.00M SEC filing ↗
  12. Biohaven Ltd. BHVN A Grant or awardnot a buy/sell decisionreported at zero 2,091 shares $0 at $0.00 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Biohaven Ltd. BHVN Common Shares (indirect) 9,876,729 $15.69 $155.0M 4 EDGAR ↗
Veradermics, Inc MANE Common Stock (indirect) 294,117 $98.51 $29.0M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where John W. Childs reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Portrait photograph: Biohaven Ltd. (company-published photograph). Original file page on biohaven.com ↗

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.